Publisher
Springer International Publishing
Reference8 articles.
1. Challis BG, Casey RT, Simpson HL, Gurnell M. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? Clin Endocrinol. 2017;86(2):163–7.
2. Zografos GN, Vasiliadis GK, Zagouri F, Aggeli C, Korkolis D, Vogiaki S, et al. Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends. World J Surg Oncol. 2010;8:14. https://doi.org/10.1186/1477-7819-8-14.
3. Lairmore TC, Ball DW, Baylin SB, Wells SA Jr. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg. 1993;217(6):595–601; discussion -3
4. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin N Am. 2011;40(2):295–311. vii
5. Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Krnoish JP, Young WL, editors. Miller’s anesthesia. 8th ed. Philadelphia: Elsevier/Saunders; 2015.